Brian Booth
- Oncology top 2%
- Hematology top 2%
- Immunology top 5%
- Biosimilars and Bioanalytical Methods 21
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 5
- Pharmacology top 1%
-
- Statistical Methods in Clinical Trials 10
-
- Clinical Laboratory Practices and Quality Control 10
- Nitric Oxide and Endothelin Effects 7
-
- Advanced Biosensing Techniques and Applications 6
-
- Neuropeptides and Animal Physiology 5
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Richard PazdurRobert JusticeRajeshwari SridharaJogarao GobburuRussell WeinerC.T. ViswanathanMark J. RosePatrick G. Swann
- Cited by
- OncologyHematologyImmunology
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Brian Booth
74 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 1.3k
- Hematology 518
- Immunology 815
- Genetics 340
- Pharmacology 265
Countries citing papers authored by Brian Booth
This map shows the geographic impact of Brian Booth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Booth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Booth more than expected).
Fields of papers citing papers by Brian Booth
This network shows the impact of papers produced by Brian Booth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Booth. The network helps show where Brian Booth may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brian Booth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 3 | |
| 6 | 2020 | 14 | |
| 7 | 2016 | 43 | |
| 8 | 2013 | 24 | |
| 9 | 2006 | 74 | |
| 10 | 2005 | 95 | |
| 11 | Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases. | 2003 | 157 |
| 12 | 2003 | 17 | |
| 13 | 2000 | 47 | |
| 14 | 2000 | 6 | |
| 15 | 1998 | 6 | |
| 16 | 1997 | 23 | |
| 17 | 1996 | 18 | |
| 18 | 1995 | 44 | |
| 19 | Caring for older people : a nurse's guide | 1993 | 0 |
| 20 | 1990 | 11 |
About Brian Booth
Brian Booth is a scholar working on Statistics and Probability, Immunology and Biophysics, having authored 77 papers that have together received 4.6k indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (21 papers), Statistical Methods in Clinical Trials (10 papers), Clinical Laboratory Practices and Quality Control (10 papers), Nitric Oxide and Endothelin Effects (7 papers), Advanced Biosensing Techniques and Applications (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Neuropeptides and Animal Physiology (5 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Oncology (1.3k citations), Hematology (518 citations) and Immunology (815 citations). Brian Booth has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Richard Pazdur, Robert Justice, Rajeshwari Sridhara, Jogarao Gobburu, Russell Weiner, C.T. Viswanathan, Mark J. Rose, Patrick G. Swann, Jeffrey Sailstad and Jerome P. Skelly. Their work appears in journals such as Clinical Cancer Research, Bioanalysis, The AAPS Journal, Journal of Clinical Oncology and Canadian Journal of Physiology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.